Arthritis Clinical Trials

The CORRONA Data Collection Program study is designed to systematically collect and document use patterns, effectiveness, and safety of DMARDs (Disease Modifying Anti-Rheumatic Drugs), biologic agents and any other treatments currently used in the management of Rheumatoid Arthritis (RA), Undifferentiated Arthritis (UA), Psoriatic Arthritis (PsA), and other rheumatic diseases. Data collected through the CORRONA Data Collection Program will be maintained in a comprehensive database (the CORRONA Database), which will be used for purposes related to clinical, outcomes, and market research. Participating physicians will have access to information about their own participating patients, and may use this information for purposes such as research and in providing patient care. It is anticipated that the study data may help improve the quality of information upon which clinical decisions are based.